Genetics of Renal Cell Carcinoma (PDQ®)–Health Professional Version
Inheritance and Risk of Renal Cell Carcinoma
Michael Topf, MD
- Assistant Professor of Otolaryngology
Michael Topf, MD
- Assistant Professor of Otolaryngology
michael.topf@vumc.org
Research Program
Alexander Bick, PhD, MD
- Associate Professor of Medicine
- Director, Division of Genetic Medicine
Alexander Bick, PhD, MD
- Associate Professor of Medicine
- Director, Division of Genetic Medicine
alexander.bick@vumc.org
Research Program
Cristina Kline-Quiroz, D.O.
- Assistant Professor
Cristina Kline-Quiroz, D.O.
- Assistant Professor
cristina.kline-quiroz@vumc.org
Research Program
Research Description
Venkataswarup Tiriveedhi, MD, PhD
- Associate Professor
- Director, Human Anatomy and Physiology
- Director, Tumor Immunology Laboratory
- Adjunct Professor, Vanderbilt University
Phone
3500 John A Merritt Blvd
Nashville, TN 37209
Nashville, TN 37209
Venkataswarup Tiriveedhi, MD, PhD
- Associate Professor
- Director, Human Anatomy and Physiology
- Director, Tumor Immunology Laboratory
- Adjunct Professor, Vanderbilt University
615-963-5779
venkataswarup.tiriveedhi@vanderbilt.edu
3500 John A Merritt Blvd
Nashville, TN 37209
Nashville, TN 37209
Research Program
Cosmas Okoro, PhD
- Professor of Organic Chemistry
Phone
Department of Chemistry, Tennessee State University
3500 John A. Merritt Blvd.
Nashville, TN 37209-1561
3500 John A. Merritt Blvd.
Nashville, TN 37209-1561
Cosmas Okoro, PhD
- Professor of Organic Chemistry
615-963-5332
cokoro@tnstate.edu
Department of Chemistry, Tennessee State University
3500 John A. Merritt Blvd.
Nashville, TN 37209-1561
3500 John A. Merritt Blvd.
Nashville, TN 37209-1561
Research Program
Deepa Magge, M.D.
- Assistant Professor in Surgery
- Division of Surgical Oncology and Endocrine Surgery
Deepa Magge, M.D.
- Assistant Professor in Surgery
- Division of Surgical Oncology and Endocrine Surgery
615-322-2391
deepa.r.magge@vumc.org
Research Program
Study tracks genomics of lung tumor behavior
A study by Vanderbilt researchers has identified genomic alterations in early stage adenocarcinomas of the lung that may indicate whether the lesions develop into aggressive tumors.
